Antimicrobial Pharmacotherapy Management of Urinary Tract Infections in Pediatric Patients

被引:7
|
作者
Lashkar, Manar O. [1 ]
Nahata, Milap C. [2 ]
机构
[1] King Abdulaziz Univ, Jeddah, Saudi Arabia
[2] Ohio State Univ, Columbus, OH 43210 USA
关键词
urinary tract infections; pediatrics; disease management; prophylaxis; antibiotic resistance;
D O I
10.1177/8755122518755402
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To discuss the risk factors, microbial resistance rates, and pharmacotherapy, including antimicrobial choices and medication dosage regimens, for urinary tract infections (UTIs) in pediatric patients. Data Sources: A MEDLINE literature search (1985 to December 2017) was performed using the following keywords and associated medical subject headings: urinary tract infection, antimicrobial, treatment, and children. Study Selection and Data Extraction: Search was conducted to identify clinical trials, systematic reviews, and guidelines. Search was filtered to include studies with age range between birth and 18 years and published in English. Additional references were identified from selected review articles. Data Synthesis: In total, 27 studies investigating microbial resistance, 31 studies assessing antimicrobial efficacy, 34 studies describing prophylaxis, and 6 systematic reviews were included. The resistance patterns differed across age groups and affected the choice of empirical therapy. If pyelonephritis is suspected, empiric antimicrobials should have high urinary and sufficient parenchymal concentrations. Nitrofurantoin has low microbial resistance rates and can generally be used empirically for treating uncomplicated cystitis in children >1 month of age. Trimethoprim-sulfamethoxazole resistance has increased and should be avoided unless local susceptibility data are available. Certain patients with recurrent UTIs or renal abnormalities may require antimicrobial prophylaxis, which may be associated with adverse effects, such as intolerability or an increased risk of microbial resistance. Conclusion: The resistance pattern of uropathogens should be considered prior to initiating therapy. Controlled trials with large samples are needed to compare the treatment duration of various antimicrobial regimens and the specific role of prophylactic antimicrobials.
引用
收藏
页码:62 / 81
页数:20
相关论文
共 50 条
  • [21] Antimicrobial Stewardship and Urinary Tract Infections
    Abbo, Lilian M.
    Hooton, Thomas M.
    ANTIBIOTICS-BASEL, 2014, 3 (02): : 174 - 192
  • [22] Antimicrobial therapy of urinary tract infections
    Dowling, PM
    CANADIAN VETERINARY JOURNAL-REVUE VETERINAIRE CANADIENNE, 1996, 37 (07): : 438 - 441
  • [23] Antimicrobial Resistance in Urinary Tract Infections
    Damm, Tiffany L.
    Cameron, Anne P.
    CURRENT BLADDER DYSFUNCTION REPORTS, 2023, 18 (01) : 1 - 9
  • [24] ANTIMICROBIAL THERAPY OF URINARY TRACT INFECTIONS
    DAESCHNER, CW
    PEDIATRIC CLINICS OF NORTH AMERICA, 1968, 15 (01) : 251 - +
  • [25] Antimicrobial Resistance in Urinary Tract Infections
    Tiffany L. Damm
    Anne P. Cameron
    Current Bladder Dysfunction Reports, 2023, 18 : 1 - 9
  • [26] Urinary bacteriophages in pediatric urinary tract infections
    Galliano, Ilaria
    Nicoli, Silvia
    Dapra, Valentina
    Zaniol, Elena
    Filomena, Rebecca
    Calvi, Cristina
    Alliaudi, Carla
    Montanari, Paola
    Savino, Francesco
    Bergallo, Massimiliano
    MINERVA BIOTECNOLOGICA, 2020, 32 (02) : 39 - 42
  • [27] Management of urinary tract infections in children in an era of increasing antimicrobial resistance
    Robinson, Joan L.
    Le Saux, Nicole
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2016, 14 (09) : 809 - 816
  • [29] Pharmacotherapy of lower urinary tract infections and pyelonephritis in children
    Bensman, Albert
    Ulinski, Tim
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2075 - 2080
  • [30] Cranberry Products for the Prophylaxis of Urinary Tract Infections in Pediatric Patients
    Durham, Spencer H.
    Stamm, Pamela L.
    Eiland, Lea S.
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (12) : 1349 - 1356